Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenovirus.”

490 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 490 results

Early research (Phase 1)Study completedNCT01598129
What this trial is testing

ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers

Who this might be right for
Malignant Solid Tumour
Targovax Oy 12
Testing effectiveness (Phase 2)Study completedNCT04566770
What this trial is testing

A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

Who this might be right for
COVID-19
CanSino Biologics Inc. 480
Early research (Phase 1)Study completedNCT01535885
What this trial is testing

Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV

Who this might be right for
Epstein-Barr Virus InfectionsAdenovirusCytomegalovirus Infections
Medical College of Wisconsin 25
Early research (Phase 1)Study completedNCT00880464
What this trial is testing

Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT03658967
What this trial is testing

Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)

Who this might be right for
Secondary Lymphedema
Herantis Pharma Plc. 39
Early research (Phase 1)Study completedNCT05213728
What this trial is testing

A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers

Who this might be right for
Norovirus Infections
Vaxart 8
Early research (Phase 1)Study completedNCT02654938
What this trial is testing

Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Panacela Labs LLC 32
Post-approval studies (Phase 4)Study completedNCT04376970
What this trial is testing

Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis

Who this might be right for
Adenoviral Keratoconjunctivitis
Military Hospital of Tunis 51
Testing effectiveness (Phase 2)UnknownNCT02844283
What this trial is testing

Ad-HGF Treatment for Myocardial Infarction

Who this might be right for
Myocardial Infarction
The First Affiliated Hospital with Nanjing Medical University 100
Early research (Phase 1)Study completedNCT00849459
What this trial is testing

Gene Therapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Max Sung 3
Testing effectiveness (Phase 2)Ended earlyNCT03387085
What this trial is testing

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

Who this might be right for
Triple Negative Breast Cancer
ImmunityBio, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT01822093
What this trial is testing

Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT

Who this might be right for
ADV Infection Post Allo-HSCT
Cell Medica Ltd 8
Testing effectiveness (Phase 2)Study completedNCT00711035
What this trial is testing

Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)

Who this might be right for
Adenovirus InfectionEBV Infection
Baylor College of Medicine 50
Early research (Phase 1)Looking for participantsNCT03878121
What this trial is testing

Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

Who this might be right for
Healthy Volunteer
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)UnknownNCT02579564
What this trial is testing

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Who this might be right for
Malignant HydrothoraxNon Small Cell Lung Cancer
Xinqiao Hospital of Chongqing 134
Testing effectiveness (Phase 2)UnknownNCT00004025
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Genzyme, a Sanofi Company 36
Early research (Phase 1)Study completedNCT01212367
What this trial is testing

Intrapleural Gene Transfer for Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Abramson Cancer Center at Penn Medicine 13
Testing effectiveness (Phase 2)Study completedNCT01470664
What this trial is testing

FST-100 in the Treatment of Acute Adenoviral Conjunctivitis

Who this might be right for
Acute Adenoviral Conjunctivitis
Shire 176
Testing effectiveness (Phase 2)Study completedNCT02918006
What this trial is testing

Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Who this might be right for
Influenza
Vaxart 179
Not applicableStudy completedNCT03284268
What this trial is testing

Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma

Who this might be right for
Retinoblastoma, Recurrent
Fundació Sant Joan de Déu 13
Load More Results